Transparent Elastomeric Respirator for Aerosol-based Protection

Sponsor
Brigham and Women's Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT04511390
Collaborator
Massachusetts General Hospital (Other), Memorial Sloan Kettering Cancer Center (Other)
100
3
1
19.2
33.3
1.7

Study Details

Study Description

Brief Summary

In times of crisis, diminishing supplies of personal protective equipment (PPE) in hospitals has forced both healthcare workers and the general population to reuse and clean PPE using anecdotal strategies which may weaken its effectiveness of preventing acquisition of airborne respiratory illnesses, such as COVID-19. There is therefore a great need to develop innovative measures to generate reusable PPE that can be safely cleaned and sterilized. A novel reusable injection molded respirator will be evaluated using qualitative and quantitative fit tests to assess overall fit and comfort.

Condition or Disease Intervention/Treatment Phase
  • Device: Transparent, reusable respirator
N/A

Detailed Description

PPE is the last line of defense in the hierarchy of controls to prevent the spread of airborne transmissible infections. There are many varieties of respirators including quarter-mask, half mask, and full facepiece respirators that filter 95, 99, or 100% of airborne particles. The elastomeric half mask respirators (EHMRs), in particular, have several advantages over commonly used N95 FFRs. Firstly, EHMRs may be cleaned, disinfected, and reused unlike FFRs that are normally discarded after a single use. EHMRs may be transparent as a result of material choice and will allow for visualization of the mouth. Lastly, they have been shown to properly fit faces after multiple rounds of decontamination.

Some disadvantages of EHMRs include the requirement to disinfect and reinspect the quality of components on the respirator by a qualified individual for proper function, as well as manual exchange of filter components. Notwithstanding, it has been found that fit testing and training to use EHMRs for healthcare personnel is not significantly different than N95 respirators and that EHMR may serve as a suitable alternative to disposable N95 respirators during public health emergencies. Furthermore, a 2018 consensus report from the National Academies of Engineering, Science, and Medicine recommended that the durability and reusability of elastomeric respirators made them desirable for stockpiling for emergencies.

A new transparent elastomeric respirator has been developed that can maintain respirator integrity after decontamination and fits many people with different face sizes and shapes. Fit testing of the respirator will be performed using an OSHA-approved testing method.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
100 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
Transparent Elastomeric Respirator to Protect Against Aerosol Transmission of Infectious Agents
Actual Study Start Date :
Jul 25, 2020
Anticipated Primary Completion Date :
Dec 30, 2021
Anticipated Study Completion Date :
Feb 28, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Transparent, reusable respirator

Transparent, reusable elastomeric respirator that has been designed to fit multiple different face sizes and shapes.

Device: Transparent, reusable respirator
A novel respirator with dual N95 filter cartridges

Outcome Measures

Primary Outcome Measures

  1. Success of fit testing [30 minutes]

    Successful fit testing using an Occupational Safety and Health Administration (OSHA)-approved testing method testing method

Secondary Outcome Measures

  1. User experience [30 minutes]

    User experience with fit, breathability and filter replacement will be assessed based on a Likert scale through a post-fit test questionnaire

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Healthcare workers that have undergone successful fit test with N95 FFR within 1 year of the trial
Exclusion Criteria:
  • Facial hair

Contacts and Locations

Locations

Site City State Country Postal Code
1 Massachusetts General Hospital Boston Massachusetts United States 02114
2 Brigham and Women's Hospital Boston Massachusetts United States 02115
3 Memorial Sloan Kettering Cancer Center New York New York United States 10065

Sponsors and Collaborators

  • Brigham and Women's Hospital
  • Massachusetts General Hospital
  • Memorial Sloan Kettering Cancer Center

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
C. Giovanni Traverso MB Bchir PhD, Assistant Professor, Brigham and Women's Hospital
ClinicalTrials.gov Identifier:
NCT04511390
Other Study ID Numbers:
  • 2020P000852
First Posted:
Aug 13, 2020
Last Update Posted:
Aug 4, 2021
Last Verified:
Aug 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Product Manufactured in and Exported from the U.S.:
No

Study Results

No Results Posted as of Aug 4, 2021